SpringWorks Therapeutics (SWTX) SEC Filings & 10K Form

$45.53
+1.33 (+3.01%)
(As of 04/26/2024 ET)

Recent SpringWorks Therapeutics SEC Filings

DateFilerForm TypeView
04/05/2024
3:13 PM
SpringWorks Therapeutics (Filer)
Form ARS
03/01/2024
4:16 PM
Smith L. Mary (Reporting)
SpringWorks Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2024
7:23 AM
SpringWorks Therapeutics (Filer)
Form 424B5
02/27/2024
7:28 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:29 AM
SpringWorks Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
5:51 AM
SpringWorks Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2024
5:44 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
5:56 PM
Pichl Daniel (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
12:09 PM
Pichl Daniel (Reporting)
SpringWorks Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
5:41 PM
EcoR1 Capital, LLC (Filed by)
SpringWorks Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:56 AM
Deep Track Capital, LP (Filed by)
SpringWorks Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
SpringWorks Therapeutics (Subject)
Form SC 13G/A
02/05/2024
8:23 PM
Pichl Daniel (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
8:24 PM
Ashar Bhavesh (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:38 PM
Ashar Bhavesh (Reporting)
SpringWorks Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:42 PM
Pichl Daniel (Reporting)
SpringWorks Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2024
9:22 AM
SpringWorks Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:06 PM
Ashar Bhavesh (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:07 PM
Cassidy James (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:09 PM
Edris Badreddin (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:10 PM
Lin Tai-An (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:11 PM
Nofi Michael (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:11 PM
Perier Francis I Jr (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:12 PM
Pichl Daniel (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:12 PM
Islam Saqib (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:13 PM
Smith L. Mary (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
8:13 PM
SpringWorks Therapeutics (Issuer)
Weinstein Herschel S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:43 PM
ORBIMED ADVISORS LLC (Filed by)
SpringWorks Therapeutics (Subject)
Form SC 13D/A
12/06/2023
3:05 PM
SpringWorks Therapeutics (Filer)
Form 424B5
12/06/2023
3:10 PM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
3:19 PM
SpringWorks Therapeutics (Filer)
Form 424B5
12/01/2023
3:01 PM
Islam Saqib (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2023
8:00 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
6:00 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
8:02 PM
BC SW, LP (Reporting)
SpringWorks Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
6:54 AM
SpringWorks Therapeutics (Filer)
Form S-3ASR
11/02/2023
5:35 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
5:38 AM
SpringWorks Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/04/2023
3:18 PM
Lin Tai-An (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
3:37 PM
Lin Tai-An (Reporting)
SpringWorks Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2023
5:33 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
08/02/2023
5:36 AM
SpringWorks Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/21/2023
3:13 PM
Hambleton Julie (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:06 PM
Hambleton Julie (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:57 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2023
4:04 PM
Schwartz Jeffrey Lawrence (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
3:25 PM
Fuhrman Alan (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
3:26 PM
Hambleton Julie (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
3:27 PM
Lewis-Hall Freda C (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
3:28 PM
LYNCH DANIEL (Reporting)
SpringWorks Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2023
3:46 PM
ORBIMED ADVISORS LLC (Filed by)
SpringWorks Therapeutics (Subject)
Form SC 13D/A
05/03/2023
5:32 AM
SpringWorks Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
5:35 AM
SpringWorks Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SWTX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners